Thursday, January 23, 2020

Barbara O’Brien on Race, Reform and Wrongful Conviction Rate Estimates

Our guest, Professor Barbara O’Brien, explains why we don’t know much about conviction error other than in murder cases. She explains factors that contribute to wrongful convictions, including mistaken cross-racial identification in sexual assault cases. Barbara also talks about the surprising frequency of “rain damage” to evidence rooms and why Texas leads the way in both executions and criminal justice reform. The two consider why having your death sentence commuted to life in prison means you are actually less likely to ever be released.

[ Note I was away when this episode was recorded so it's just Corey and Barbara. ]


Barbara O'Brien (Faculty Profile)

The National Registry Of Exonerations

man·i·fold /ˈmanəˌfōld/ many and various.

In mathematics, a manifold is a topological space that locally resembles Euclidean space near each point.

Steve Hsu and Corey Washington have been friends for almost 30 years, and between them hold PhDs in Neuroscience, Philosophy, and Theoretical Physics. Join them for wide ranging and unfiltered conversations with leading writers, scientists, technologists, academics, entrepreneurs, investors, and more.

Steve Hsu is VP for Research and Professor of Theoretical Physics at Michigan State University. He is also a researcher in computational genomics and founder of several Silicon Valley startups, ranging from information security to biotech. Educated at Caltech and Berkeley, he was a Harvard Junior Fellow and held faculty positions at Yale and the University of Oregon before joining MSU.

Corey Washington is Director of Analytics in the Office of Research and Innovation at Michigan State University. He was educated at Amherst College and MIT before receiving a PhD in Philosophy from Stanford and a PhD in a Neuroscience from Columbia. He held faculty positions at the University Washington and the University of Maryland. Prior to MSU, Corey worked as a biotech consultant and is founder of a medical diagnostics startup.

No comments:

Blog Archive